
Beneficient (NASDAQ:BENF – Free Report) – Sidoti Csr reduced their Q4 2027 EPS estimates for shares of Beneficient in a note issued to investors on Wednesday, November 12th. Sidoti Csr analyst B. Mccarthy now expects that the company will earn $0.04 per share for the quarter, down from their prior estimate of $0.08. The consensus estimate for Beneficient’s current full-year earnings is ($2.29) per share.
A number of other analysts have also recently issued reports on BENF. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beneficient in a research report on Tuesday. Wall Street Zen upgraded Beneficient to a “sell” rating in a research note on Saturday, November 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.
Beneficient Trading Up 1.1%
Beneficient stock traded up $0.01 during midday trading on Friday, reaching $0.52. 250,862 shares of the company’s stock were exchanged, compared to its average volume of 7,153,126. Beneficient has a 52 week low of $0.22 and a 52 week high of $2.36. The stock’s 50-day simple moving average is $0.59 and its 200 day simple moving average is $0.42.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Featured Articles
- Five stocks we like better than Beneficient
- High Flyers: 3 Natural Gas Stocks for March 2022
- Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since
- With Risk Tolerance, One Size Does Not Fit All
- Here’s What We Learned From AST SpaceMobile’s Q3 Earnings Report
- Growth Stocks: What They Are, Examples and How to Invest
- 3 Stocks Quietly Leveraging AI While Everyone Chases NVIDIA
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
